ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $9,496,000 | +7.3% | 6,501,791 | +4.4% | 0.00% | 0.0% |
| Q4 2016 | $8,847,000 | -14.0% | 6,228,914 | +6.0% | 0.00% | 0.0% |
| Q3 2016 | $10,287,000 | +7.6% | 5,877,917 | +5.1% | 0.00% | 0.0% |
| Q2 2016 | $9,557,000 | -30.6% | 5,590,158 | -20.0% | 0.00% | 0.0% |
| Q1 2016 | $13,761,000 | -11.9% | 6,984,029 | -15.0% | 0.00% | -50.0% |
| Q4 2015 | $15,619,000 | -57.2% | 8,218,848 | -1.6% | 0.00% | -50.0% |
| Q1 2015 | $36,496,000 | +30.8% | 8,350,975 | +3.9% | 0.00% | +33.3% |
| Q4 2014 | $27,905,000 | -12.0% | 8,041,257 | +6.3% | 0.00% | 0.0% |
| Q3 2014 | $31,693,000 | -18.5% | 7,563,753 | +14.0% | 0.00% | -25.0% |
| Q2 2014 | $38,896,000 | -14.3% | 6,637,729 | -7.9% | 0.00% | -20.0% |
| Q1 2014 | $45,395,000 | -51.4% | 7,205,247 | -44.0% | 0.01% | -16.7% |
| Q4 2013 | $93,383,000 | +124.4% | 12,870,326 | +63.0% | 0.01% | +20.0% |
| Q3 2013 | $41,618,000 | -12.0% | 7,897,052 | +28.6% | 0.01% | -16.7% |
| Q2 2013 | $47,289,000 | – | 6,141,696 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
| Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
| GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
| Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
| TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
| Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
| Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |